Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study.

Talip E Eroglu Ruben CoronelPatrick C Souverein

Published in: European heart journal. Cardiovascular pharmacotherapy (2024)

SGLT-2is were associated with a reduced risk of AF in patients with type 2 diabetes compared to other second-line to third-line antidiabetic drugs. This reduced risk occurs in both sexes but more prominently among women.

Keyphrases

atrial fibrillation
polycystic ovary syndrome
catheter ablation
oral anticoagulants
left atrial
direct oral anticoagulants
percutaneous coronary intervention
pregnancy outcomes
breast cancer risk
type diabetes
coronary artery disease
adipose tissue
acute coronary syndrome
drug induced
skeletal muscle